MBOT - Microbot Medical, Inc Long-Term Liabilities to Capital

The R&D potential of Microbot Medical Inc. (MBOT) is currently peaking as the company prepares final documentation for the launch of its disposable robotic system. Secure air transport of precision devices ensures a stable supply chain to clinics. The market capitalization trend, featuring the 0.01 metric, clearly demonstrates the company's dynamics. The business relies on unique LIBERTY patents, creating the world's first fully interchangeable platform for endovascular interventions.

This ratio determines the degree of business dependence on long-term borrowings relative to equity, measuring financial stability and the level of debt leverage. By analyzing the share of long-term loans within the capital structure, an investor distinguishes actual liability reduction from asset revaluation, which is critically important for Microbot Medical Inc. (MBOT) during its reputation-building phase and the implementation of innovative microrobots in surgery.